Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Zura Bio Limited (ZURA) stock profile

Zura Bio Limited is a clinical-stage biotechnology company that focuses on developing novel medicines for immune and inflammatory disorders. The company develops ZB-168, an anti-IL7Rα inhibitor that impacts diseases driven by IL7 and TSLP biological pathways, and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. Zura Bio is based in San Diego, California.

Key facts

SymbolZURA
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CEOSandeep C. Kulkarni
Employees30
HeadquartersSan Diego, CA, US
IPO2023-03-21
Websitezurabio.com

Explore ZURA on Vantafin

  • Zura Bio Limited Overview
  • Zura Bio Limited Financials
  • Zura Bio Limited News
  • Zura Bio Limited Events
  • Zura Bio Limited SEC filings
  • Zura Bio Limited Insider transactions

Frequently asked questions

What does Zura Bio Limited (ZURA) do?
Zura Bio Limited is a clinical-stage biotechnology company that focuses on developing novel medicines for immune and inflammatory disorders. The company develops ZB-168, an anti-IL7Rα inhibitor that impacts diseases driven by IL7 and TSLP biological pathways, and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. Zura Bio is based in San Diego, California.
Where is ZURA stock listed?
Zura Bio Limited trades under the ticker ZURA on NASDAQ.
How can I research ZURA's financials and filings?
Vantafin provides Zura Bio Limited's income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the ZURA profile.